Takao Yamori
Minato, 1050003, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Associations between Anticholinergic Use and Dementia Risk in a Prevalent-User Cohort: Analysis of Japanese Medication Histories as Real-World Data.
Journal: Biological & pharmaceutical bulletin
Published: April 08, 2026
Reforms of regulatory pathways for approval of new antineoplastic drugs in Japan from 2004 to 2019 and accompanying changes in pivotal clinical trial designs.
Journal: Investigational new drugs
Published: June 19, 2021
A Potential Role of Adhesion Molecules on Lung Metastasis Enhanced by Local Inflammation.
Journal: Anticancer research
Published: August 26, 2020
A Potential Mechanism of Tumor Progression during Systemic Infections Via the Hepatocyte Growth Factor (HGF)/c-Met Signaling Pathway.
Journal: Journal of clinical medicine
Published: May 21, 2020
Possible Contribution of Drug Approval Summaries Published by Drug Regulatory Authorities on Scientific Discussion and Drug Development.
Journal: Clinical pharmacology in drug development
Published: August 20, 2019
Discovery of Inhibitors of Membrane Traffic from a Panel of Clinically Effective Anticancer Drugs.
Journal: Biological & pharmaceutical bulletin
Published: February 22, 2019
Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines.
Journal: Oncotarget
Published: April 10, 2018
Family-wide Analysis of the Inhibition of Arf Guanine Nucleotide Exchange Factors with Small Molecules: Evidence of Unique Inhibitory Profiles.
Journal: Biochemistry
Published: September 01, 2017
Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors.
Journal: Oncotarget
Published: August 02, 2017
TUFT1 interacts with RABGAP1 and regulates mTORC1 signaling.
Journal: Cell discovery
Published: May 27, 2017
Last Updated: 09/26/2026